Healthtech startup CribMD acquires Charisland Pharmaceuticals

NIGERIA – CribMD, a healthtech startup, has announced its acquisition of Charisland Pharmaceuticals Group to ensure fast and efficient one-hour drug deliveries to its patients across Nigeria. The acquisition comes on the heels of CribMD’s US$2.6 million seed round in May 2021, which the startup says was oversubscribed. According to CribMD’s CEO, Ifeanyi Ossai, users would not need to wait two days for the delivery of their medications. Now, it can be sent to their homes, offices, or hotels in as little as one hour. Charisland Pharmaceuticals Group was founded…

Read More